1-15 of 15
Evan F. Lind
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BCL-2 Inhibitor Venetoclax Shows Synergistic Effects on CD8 T Cell Proliferation and Blast Death in Vitro When Combined with Anti PD-1 Checkpoint Inhibitor

Hyun Cho, Evan F. Lind, Ravina Pandita, Yoko Kosaka
Journal: Blood
Blood (2024) 144 (Supplement 1): 6078.
https://doi.org/10.1182/blood-2024-212291
Published: 2024
Journal Articles

Characterizing the Role of Interferon-γ Signaling in Natural Killer Cell Dysfunction in Venetoclax-Resistant Acute Myeloid Leukemia

Daniel J. Chandra, Faith Burns, Austin Nguyen, Elias Pavlatos, Khauan Bainha, Nicola Long, Yoko Kosaka, Jessica Mulkey, Joanna Pucilowska, Evan F. Lind, Jeffrey W. Tyner, Jennifer N. Saultz
Journal: Blood
Blood (2024) 144 (Supplement 1): 4815.
https://doi.org/10.1182/blood-2024-199437
Published: 2024
Journal Articles

Combined Single Cell Flow Cytometry and Imaging Analyses Reveal Immunomodulatory Effects Exerted By Targeted Phospho-SYK Inhibitors with Elevated Sensitivity in NPM1 Mutated AML

Bridget A Robinson, Philipp Sergeev, Yoko Kosaka, Thomas Jacob, Andy Kaempf, Evan F. Lind, Cristina Tognon, Luis A. Carvajal, Jorge F. DiMartino, Caroline A. Heckman, Tania Q Vu
Journal: Blood
Blood (2023) 142 (Supplement 1): 5037.
https://doi.org/10.1182/blood-2023-186506
Published: 2023
Journal Articles

Prognostic Significance of NCAM1 (CD56) Expression in AML Patients Treated with HMA+Venetoclax

Jennifer N. Saultz, Manoj Rai, Faith Burns, Daniel J Chandra, Sunil K Joshi, Curtis A. Lachowiez, Andy Kaempf, Andrew N Nemecek, Yoko Kosaka, Evan F. Lind, Stephen E. Kurtz, Nicola Long, Rachel Cook, Gabrielle Meyers, Arpita Gandhi, Jessica T. Leonard, Brandon Hayes-Lattin, Laura F. Newell, Richard T Maziarz, Elie Traer, Ronan T. Swords, Theodore P Braun, Cristina Tognon, Jeffrey W Tyner
Journal: Blood
Blood (2023) 142 (Supplement 1): 5762.
https://doi.org/10.1182/blood-2023-188311
Published: 2023
Journal Articles

High Dimensional Clustering and Identification of Immune Cell Hybrid Populations in B-ALL across the Disease Continuum

Matthew Newman, Hong De Sa, Kaelan Byrd, Ranish Patel, Michael S. Parappilly, Yoko Kosaka, Evan F. Lind, Jessica T. Leonard
Journal: Blood
Blood (2023) 142 (Supplement 1): 5627.
https://doi.org/10.1182/blood-2023-180248
Published: 2023
Journal Articles

The Aryl Hydrocarbon Receptor Defines a Unique Genomic and Immune Signature in AML Characterized By Monocytic Differentiation, Venetoclax Resistance and Is Targetable By Ahr Antagonist

Jennifer N. Saultz, Daniel Bottomly, Faith Burns, Kaelan Byrd, Yoko Kosaka, Shannon K. McWeeney, Stephen E. Kurtz, Guang Fan, Andy Kaempf, Karen McGovern, Lei Wang, Marta Sanchez-Martin, Dan S Kaufman, Evan F. Lind, Jeffrey W. Tyner
Journal: Blood
Blood (2022) 140 (Supplement 1): 3071–3072.
https://doi.org/10.1182/blood-2022-163166
Published: 2022
Journal Articles

Aryl Hydrocarbon Receptor (AHR) Gene Expression in AML Is Associated with FLT3-ITD+ AML and HLA-E Induced Immune Resistance Reversed By Ik-364

Jennifer N. Saultz, Evan F. Lind, Jeffrey W. Tyner, Kaelan Byrd, Shannon K. McWeeney, Yoko Kosaka, Karen McGovern, Lei Wang, Marta Sanchez-Martin
Journal: Blood
Blood (2021) 138 (Supplement 1): 1161.
https://doi.org/10.1182/blood-2021-147589
Published: 2021
Journal Articles

CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells

David K. Edwards, V, Kevin Watanabe-Smith, Angela Rofelty, Alisa Damnernsawad, Ted Laderas, Adam Lamble, Evan F. Lind, Andy Kaempf, Motomi Mori, Mara Rosenberg, Amanda d’Almeida, Nicola Long, Anupriya Agarwal, David Tyler Sweeney, Marc Loriaux, Shannon K. McWeeney, Jeffrey W. Tyner
Journal: Blood
Blood (2019) 133 (6): 588–599.
https://doi.org/10.1182/blood-2018-03-838946
Published: 2019
Includes: Supplemental data
Journal Articles

Altered T Cell Subsets and Function in Patients with Acute Lymphoblastic Leukemia

Jessica Leonard, MD, Yoko Kosaka, PhD, Matthew T Newman, BS, Adam J. Lamble, MD, Pavani Malla, MS, Brian J. Druker, MD, Jeffrey W. Tyner, PhD, Bill H. Chang, MD PhD, Evan F. Lind, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1547.
https://doi.org/10.1182/blood-2018-99-119409
Published: 2018
Journal Articles

Immunogenomic Exploration of the Acute Myeloid Leukemia Microenvironment Identifies Determinants of T-Cell Fitness

Lauren K. Brady, PhD, David Soong, PhD, Evan F. Lind, PhD, Yoko Kosaka, PhD, Adam J. Lamble, MD, Michael Schaffer, PhD, Brendan P. Hodkinson, PhD, Clare Lefave, PhD, Ted Laderas, PhD, Shannon K. McWeeney, PhD, Homer Adams, III, PhD, Yann Abraham, PhD, Pegah Safabakhsh, MS, Jeffrey W. Tyner, PhD, Brian J. Druker, MD, Fei Huang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2750.
https://doi.org/10.1182/blood-2018-99-118424
Published: 2018
Journal Articles

T-Cell Suppression By Src/ABL Kinase Inhibitors When Combined with Blinatumomab in Ph+ Acute Lymphoblastic Leukemia

Jessica Leonard, MD, Yoko Kosaka, PhD, Pavani Malla, MS, Brandon Hayes-Lattin, MD, Adam J. Lamble, MD, Brian J. Druker, MD, Jeffrey W. Tyner, PhD, Bill H. Chang, MD PhD, Evan F. Lind, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2694.
https://doi.org/10.1182/blood-2018-99-119301
Published: 2018
Journal Articles

Mass Cytometry As a Modality to Identify Candidates for Immune Checkpoint Inhibitor Therapy within Acute Myeloid Leukemia

Adam Lamble, MD, Yoko Kosaka, PhD, Fei Huang, A Kate Sasser, PhD, Homer Adams, III, PhD, Cristina E. Tognon, Ted Laderas, PhD, Shannon K. McWeeney, Marc M. Loriaux, Jeffrey W. Tyner, Brian J. Druker, MD, Evan F. Lind, PhD
Journal: Blood
Blood (2016) 128 (22): 2829.
https://doi.org/10.1182/blood.V128.22.2829.2829
Published: 2016
Journal Articles

Enhanced VISTA Expression in a Subset of Patients with Acute Myeloid Leukemia

Adam Lamble, MD, Yoko Kosaka, PhD, Fei Huang, A Kate Sasser, PhD, Homer Adams, III, PhD, Cristina E. Tognon, Ted Laderas, PhD, Shannon K. McWeeney, Marc M. Loriaux, Jeffrey W. Tyner, Brian J. Druker, MD, Evan F. Lind, PhD
Journal: Blood
Blood (2016) 128 (22): 4056.
https://doi.org/10.1182/blood.V128.22.4056.4056
Published: 2016
Journal Articles

Defining the Immune Microenvironment in Patients with Acute Myeloid Leukemia

Adam Lamble, MD, Yoko Kosaka, PhD, Pierrette Lo, MS, Fei Huang, PhD, Kate Sasser, PhD, Cristina E. Tognon, PhD, Marc Loriaux, MD PhD, Jeffrey W. Tyner, PhD, Brian J. Druker, MD, Evan F. Lind, PhD
Journal: Blood
Blood (2015) 126 (23): 1374.
https://doi.org/10.1182/blood.V126.23.1374.1374
Published: 2015
Journal Articles

The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation

Li-Fan Lu, Cory L. Ahonen, Evan F. Lind, Vanitha S. Raman, W. James Cook, Ling-Li Lin, Randolph J. Noelle
Journal: Blood
Blood (2007) 110 (1): 193–200.
https://doi.org/10.1182/blood-2006-07-038414
Published: 2007